Effect of Cyclooxygenase-2 Glycosylation on Downstream Expression of E-Cadherin and β-Catenin in MCF-7 Breast Cancer Cells

Cyclooxygenase-2 (COX-2) is an enzyme that helps catalyze the formation of prostaglandins, which promote inflammation, pain, and fever and maintain other normal physiological functions throughout the body. However, the overexpression of COX-2 has been found to play a role in various diseases including breast cancer. COX-2 exists as two major glycoforms— 72 kDa and 74 kDa— due to the glycosylation site Asn580 which is glycosylated 50% of the time. Past studies from our lab have shown that this glycosylation regulates COX-2 protein turnover in the cell3. The proteins E-cadherin— a tumor suppressor— and β-catenin— a tumor driver— can be regulated by COX-2 activityhttps://scholar.dominican.edu/natural-sciences-and-mathematics-faculty-research-posters/1002/thumbnail.jp